Suzanne Bakewell, Ph.D., is Chief Scientific Officer at Omeza, where she leads research and development, clinical development, regulatory affairs, and intellectual property rights for Omeza’s line of wound care products. She is an accomplished principal scientist and leader with expertise in early-stage drug and medical device development, cancer biology, and nanotechnology.
Prior to joining Omeza, Ms. Bakewell led early-stage drug development and designed translational studies for clinical trials in both industry and academia. Among her roles, she was Principal Consultant at Beeston Biotech Consulting, LLC, where she served as Advisor and Director for Preclinical Development and IND submissions; Science and Business Advisor for Early-Stage Drug Development; Consultant for Investigator-initiated Clinical Trials; Author and Editor for Grant Applications and Scientific Manuscripts; External Reviewer of Grants for UK-MRC; and Science Consultant for International Environmental and Public Health NGOs.
Prior to this role, Ms. Bakewell spent seven years at Intezyne Technologies, rising to Vice President of Preclinical Development, where she was instrumental in taking IND drugs from synthesis into phase I clinical trials. She also has considerable scientific experience, with her primary area of interest in large xenograft studies to evaluate the efficacy, toxicity, and pharmacokinetics of a nanoparticle cytotoxic drug delivery platform.
Ms. Bakewell conducted her postdoctoral fellowship in oncology and cancer biology at the University of Pennsylvania and earned her Ph.D. in physiology at University of Arkansas for Medical Sciences. Her doctoral research at Washington University focused on cancer metastasis to bone and the tumor microenvironment. As a Susan G. Komen Fellow in the Dr. Lewis Chodosh lab at the University of Pennsylvania, Ms. Bakewell studied cancer cell dormancy and disease recurrence. Bakewell also has a Graduate Certificate in Environmental Health and volunteers as a writer for U.N. reports and grants to support NGOs in developing nations.
